ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis

Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation

1998 • 5,369 citations

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

1987 • 4,980 citations

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1998 • 4,184 citations

Vitamin D

1979 • 3,814 citations

Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units

1987 • 3,281 citations

Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families

1999 • 2,238 citations

Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of Osteoporosis

1995 • 1,661 citations

The Role of the Vitamin D Endocrine System in Health and Disease

1989 • 1,041 citations

A microtomographic system for the nondestructive evaluation of bone architecture

1996 • 885 citations

Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis

1996 • 730 citations

Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95: 3597-602

1998 • 669 citations

1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue Culture

1972 • 631 citations

Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families

1999 • 479 citations

Bone marrow, cytokines, and bone remodeling

1995 • 390 citations

Effects of 1?-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis

1994 • 227 citations

Evidence That 1,25-Dihydroxyvitamin D₃Is the Physiologically Active Metabolite of Vitamin D₃*

1985 • 157 citations

Alfacalcidol Inhibits Bone Resorption and Stimulates Formation in an Ovariectomized Rat Model of Osteoporosis: Distinct Actions from Estrogen

2000 • 155 citations

Vitamin D analogs with low affinity for the vitamin D binding protein: Enhanced in vitro and decreased in vivo activity

1991 • 124 citations

Regulatory activities of 2β-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolism

1989 • 108 citations

A novel synthetic vitamin D analogue, 2?-(3-hydroxypropoxy)1?, 25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats

1994 • 89 citations

The Advantage of Alfacalcidol Over Vitamin D in the Treatment of Osteoporosis

1999 • 82 citations

Synthetic Studies of Vitamin D Analogues. XIV. Synthesis and Calcium Regulating Activity of Vitamin D3 Analogues Bearing a Hydroxyalkoxy Group at the 2.BETA.-Position.

1993 • 82 citations

Vitamin D Therapy of Osteoporosis: Plain Vitamin D Therapy Versus Active Vitamin D Analog (D-Hormone) Therapy

1999 • 71 citations

Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats

1996 • 57 citations

Vitamin D and Osteoporosis

2005 • 48 citations

ChemInform Abstract: Synthetic Studies of Vitamin D Analogues. Part 14. Synthesis and Calcium Regulating Activity of Vitamin D3 Analogues (IV) Bearing a Hydroxyalkoxy Group at the 2β‐Position.

1995 • 25 citations

Vitamin D and Its Metabolites in the Management of Osteoporosis

2001 • 17 citations

The effect of vitamin D on osteoblasts and osteoclasts

1999 • 17 citations

Effects of two new vitamin D3 derivatives, 22-oxa-1α-25-dihydroxyvitamin D3 (OCT) and 2β-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture

1993 • 16 citations

Characteristics of 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)-calcitriol (ED-71).

1997 • 14 citations